|
|||
Federal Upper Limits on DrugsIn 1987, regulations limited the amount which Medicaid could reimburse for drugs with available generic drugs under the federal upper limit program. These limits are intended to assure that the Federal government acts as a prudent buyer of drugs. The concept of the upper limits program is to achieve savings by taking advantage of the current market prices. Until the passage of the Omnibus Budget Reconciliation Act of 1990 (OBRA '90), the Federal Upper Limit (FUL) could be established only if all versions of a drug product had been classified as therapeutically equivalent (A-rate) by the FDA in its publication "Approved Drug Products with Therapeutic Equivalence Evaluations" and at least three suppliers were listed in the current editions of published national compendia. OBRA '90 expanded that criteria and permitted the establishment of a FUL for a drug product if there are three (or more) versions of the product rated therapeutically equivalent (A-rated) regardless of the ratings of other versions (B-rated) and at least three suppliers are listed in the current editions of published national compendia. The Federal Upper Limit drug listing is published in the State Medicaid Manual, Part 6, Payment for Services, Addendum A
Contacts:
Last Modified on Tuesday, September 28, 2004
|
|||
Centers for Medicare & Medicaid Services
|